Recombinant human alpha-glucosidase from rabbit milk ... [Lancet. 2000] - PubMed

Save items

loading

Related citations in PubMed

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. [Pediatrics. 2004]
Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, et al. Pediatrics. 2004 May; 113(5):e448-57.
Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. [J Inherit Metab Dis. 2001]
Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk.
Van den Hout JM, Reuser AJ, de Klerk JB, Arts WF, Smeitink JA, Van der Ploeg AT. J Inherit Metab Dis. 2001 Apr; 24(2):266-74.
Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease. [Pediatr Cardiol. 2008]
Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease.
Levine JC, Kishnani PS, Chen YT, Herlong JR, Li JS. Pediatr Cardiol. 2008 Nov; 29(6):1033-42. Epub 2008 Jul 26.
Review Enzyme therapy for Pompe disease: from science to industrial enterprise. [Eur J Pediatr. 2002]
Review Enzyme therapy for Pompe disease: from science to industrial enterprise.
Reuser AJ, Van Den Hout H, Bijvoet AG, Kroos MA, Verbeet MP, Van Der Ploeg AT. Eur J Pediatr. 2002 Oct; 161 Suppl 1:S106-11. Epub 2002 Aug 13.
Review Pompe's disease. [Lancet. 2008]
Review Pompe's disease.
van der Ploeg AT, Reuser AJ. Lancet. 2008 Oct 11; 372(9646):1342-53.

See reviews... See all...

Cited by 18 PubMed Central articles

Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy. [J Inherit Metab Dis. 2012]
Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy.
van Gelder CM, van Capelle CI, Ebbink BJ, Moor-van Nugteren I, van den Hout JM, Hakkesteegt MM, van Doorn PA, de Coo IF, Reuser AJ, de Gier HH, et al. J Inherit Metab Dis. 2012 May; 35(3):505-11. Epub 2011 Oct 19.
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. [Orphanet J Rare Dis. 2011]
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy.
Güngör D, de Vries JM, Hop WC, Reuser AJ, van Doorn PA, van der Ploeg AT, Hagemans ML. Orphanet J Rare Dis. 2011 Jun 1; 6:34. Epub 2011 Jun 1.
Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. [Genet Med. 2011]
Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy.
Forsha D, Li JS, Smith PB, van der Ploeg AT, Kishnani P, Pasquali SK, Late-Onset Treatment Study Investigators. Genet Med. 2011 Jul; 13(7):625-31.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.
Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.
Lancet. 2000 Jul 29 ;356(9227):397-8.

PubMed
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised t...
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Lancet. 2000 Jul 29 ;356(9227):385-90.

PubMed
Randomised trial of effects of calcium antagonists compared with diuretics and b...
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Lancet. 2000 Jul 29 ;356(9227):359-65.

PubMed
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (...
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).
Nature. 2000 Aug 24 ;406(6798):906-10.

PubMed
When Brazilians achieve, it's against all the odds.
When Brazilians achieve, it's against all the odds.
Nature. 2000 Aug 24 ;406(6798):826.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 18 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information